Clinical Trials Logo

Clinical Trial Summary

This observational study evaluates the clinical, biochemical and haemodynamic effects of large-volume paracentesis (LVP) in 50 patients with and without signs of inflammation


Clinical Trial Description

Ascites is one of the common complications in advanced liver cirrhosis. Large-volume paracentesis (LVP) is a widely used symptomatic intervention to remove large amounts of peritoneal fluid. Despite a low rate of interventional-associated complications like fistula or non life-threatening bleeding LVP induces an impairment of circulatory function. The hypothesis is that haemodynamic changes can be detected by non-invasive monitoring and that these haemodynamic changes could be associated to postinterventional organ dysfunction or complications. Additionally the investigators hypothesize that paracentesis-induced circulatory dysfunction could also be associated to present clinical and laboratory signs of inflammation or infection and could influenced by increased viable and non-viable bacterial translocation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02799160
Study type Observational
Source Charite University, Berlin, Germany
Contact
Status Active, not recruiting
Phase
Start date October 1, 2016
Completion date June 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04322201 - Continuous Passive Paracentesis for Intra-abdominal Hypertension N/A
Recruiting NCT05964439 - Augmented Reality Ultrasound Guidance N/A
Recruiting NCT03506893 - Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients N/A
Completed NCT04245553 - Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis? N/A